Solid Biosciences (SLDB)
(Delayed Data from NSDQ)
$6.82 USD
-0.01 (-0.15%)
Updated Aug 4, 2025 04:00 PM ET
After-Market: $6.82 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Solid Biosciences Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
SLDB 6.82 -0.01(-0.15%)
Will SLDB be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SLDB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SLDB
Wall Street Analysts Believe Solid Biosciences (SLDB) Could Rally 198.18%: Here's is How to Trade
SLDB Stock Rallies 60% in a Month: Here's What You Should Know
SLDB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Biotech Stock Roundup: MRNA's Q4 Results, GILD's Update & Other News
SLDB Stock Up as FDA Clears IND for SGT-212 in Friedreich's Ataxia
Other News for SLDB
Solid Biosciences (SLDB) Awards Restricted Stock Units to New Employees
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | SLDB Stock News
Solid Biosciences reports inducement grants under Nasdaq listing rule
Solid Biosciences (SLDB) Advances Gene Therapy with FDA Fast Track
Solid Biosciences gets FDA fast track status for heart disease therapy